Repetitive probing identifies nasolacrimal duct obstructions

Article

Repetitive probing with intranasal endoscopic imaging provides information about congenital nasolacrimal duct obstructions.

Repetitive probing with intranasal endoscopic imaging provides information about congenital nasolacrimal duct obstructions, claims a paper in the European Journal of Ophthalmology.

Dr S. Okumus et al., Department of Ophthalmology, Faculty of Medicine, University of Gaziantep, Gaziantep, Turkey, included 84 eyes of 64 patients who experienced unsuccessful primary probing. Each patient was divided into three groups according to the number of unsuccessful probing attempts. Group one included 50 eyes who experienced one unsuccessful probing, group two consisted of 23 eyes with two unsuccessful probings and group three had 11 eyes that underwent three.

History taking, clinical examination and fluorescence disappearance test confirmed the diagnosis of congenital nasolacrimal duct obstruction. Nasal endoscopic-assisted probing was performed in all eyes. All patients were followed-up on the first week, first month and third month, postoperatively.

The reasons for failure, as determined by endoscopy, were functional insufficiency in 8.3% of patients, lower nasal concha tension in 4.7%, thin membrane in Hasner valve in 3.6%, thick membrane and fibrosis in the distal side of the duct in 21.4%, probe progressed submucosally on the nasal wall in 33.3%, different exit location in the nose in 20.2%, nasal mucosa ballooning in the distal side of the duct in 4.7%, mucocele in 2.4% and nasal polyposis in 1.2%.

The predicted success rates for groups one, two and three were 86%, 69.5% and 54.5%, respectively. Repetitive probings via nasal endoscopy was able to provide information on the location and shape of the obstruction.

Please click here to read the abstract.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.